Article
ABCG2 regulatory single-nucleotide polymorphisms alter in vivo enhancer activity and expression.
Pharmacogenetics and genomics - 1 Dec 2017
Eclov Rachel J, Kim Mee J, Chhibber Aparna, Smith Robin P, Ahituv Nadav, Kroetz Deanna L
Abstract excerpt
OBJECTIVES: The expression and activity of the breast cancer resistance protein (ABCG2) contributes toward the pharmacokinetics of endogenous and xenobiotic substrates. The effect of genetic variation on the activity of cis-regulatory elements and nuclear response elements in the ABCG2 locus and their contribution toward ABCG2 expression have not been investigated systematically. In this study, the effect of...
Read the complete abstract on PubMedTopics
Share this publication in a Topic to start or enrich a Post.
